Mar-Lee’s John Gravelle shows the company’s Class 100,000 molding room. The booming medical device industry in Massachusetts is giving a much-needed boost to the region’s injection molding industry.
Zacks Investment Research on MSN
908 Devices (MASS) moves 19.2% higher: Will this strength last?
908 Devices Inc. MASS shares ended the last trading session 19.2% higher at $6.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
Earnings call 908 Devices reported Q2 2025 revenue of $13M, up 14% YoY, driven by strong handheld device sales and record XplorlR placements. The company reaffirmed its goal of adjusted EBITDA ...
The latest price target for 908 Devices (NASDAQ:MASS) was reported by Leerink Partners on August 5, 2025. The analyst firm set a price target for $12.00 expecting MASS to rise to within 12 months (a ...
Please provide your email address to receive an email when new articles are posted on . Las Vegas — An investigational proximal flow blockage cerebal protection device may offer something that ...
The Affordable Care Act's 2.3% tax on medical device revenue is meant to pay for itself through a long-term boost in insured patients, but execs in the med tech hotbed of Massachusetts remain ...
Earnings call Q1 2025 revenue from continuing operations rose 59% YoY to $11.8M, driven by 86% growth in handheld product revenue. Adjusted EBITDA loss improved nearly 50% YoY. Management reiterated ...
908 Devices Inc. (NASDAQ:MASS) Q2 2025 Earnings Call Transcript August 5, 2025 908 Devices Inc. misses on earnings expectations. Reported EPS is $-0.37087 EPS, expectations were $-0.16. Operator: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback